Exact Mass: 552.1132

Exact Mass Matches: 552.1132

Found 60 metabolites which its exact mass value is equals to given mass value 552.1132, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bilobetin

8-(5-(5,7-BIS(OXIDANYL)-4-OXIDANYLIDENE-CHROMEN-2-YL)-2-METHOXY-PHENYL)-2-(4-HYDROXYPHENYL)-5,7-BIS(OXIDANYL)CHROMEN-4-ONE

C31H20O10 (552.1056)


Bilobetin is a flavonoid oligomer. Bilobetin is a natural product found in Austrocedrus chilensis, Fitzroya cupressoides, and other organisms with data available. From Ginkgo biloba (ginkgo). Bilobetin is found in ginkgo nuts and fats and oils. Bilobetin is found in fats and oils. Bilobetin is from Ginkgo biloba (ginkgo Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1].

   

Podocarpusflavonea

4H-1-Benzopyran-4-one, 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, monomethyl ether

C31H20O10 (552.1056)


Podocarpusflavone a is a flavonoid oligomer. Podocarpusflavone A is a natural product found in Podocarpus elongatus, Podocarpus urbanii, and other organisms with data available.

   

sotetsuflavon

4H-1-benzopyran-4-one, 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-

C31H20O10 (552.1056)


Sotetsuflavone is a natural product found in Torreya fargesii var. yunnanensis, Taxus baccata, and other organisms with data available.

   

Ochnaflavone

4H-1-Benzopyran-4-one, 2-(4-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenoxy)phenyl)-5,7-dihydroxy-

C31H20O10 (552.1056)


4-O-Methylochnaflavone is a natural product found in Lonicera japonica, Ochna integerrima, and Ochna jabotapita with data available.

   

Podocarpusflavone

4H-1-Benzopyran-4-one, 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, monomethyl ether

C31H20O10 (552.1056)


Podocarpusflavone a is a flavonoid oligomer. Podocarpusflavone A is a natural product found in Podocarpus elongatus, Podocarpus urbanii, and other organisms with data available.

   

Sotetsuflavone

Sotetsuflavone

C31H20O10 (552.1056)


   

7-Methylagathisflavone

7-Methylagathisflavone

C31H20O10 (552.1056)


   

Robustaflavone 7-methyl ether

Robustaflavone 7-methyl ether

C31H20O10 (552.1056)


   

Ochnaflavone 4-methyl ether

Ochnaflavone 4-methyl ether

C31H20O10 (552.1056)


   

Taiwaniaflavone 7-O-methyl ether

Taiwaniaflavone 7-O-methyl ether

C31H20O10 (552.1056)


   

7-O-Methylcupressuflavone

7-O-Methylcupressuflavone

C31H20O10 (552.1056)


   

robustaflavone 4-methyl ether

robustaflavone 4-methyl ether

C31H20O10 (552.1056)


   

Sequoiaflavone

7-O-methylamentoflavone

C31H20O10 (552.1056)


   

Neocryptomerin

5,7-Dihydroxy-6-[4-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

C31H20O10 (552.1056)


Neocryptomerin is a natural product found in Podocarpus macrophyllus with data available.

   

CHEMBL3589108

CHEMBL3589108

C31H20O10 (552.1056)


   

7-O-Methylagathisflavone

7-O-Methylagathisflavone

C31H20O10 (552.1056)


   

Cryptomerin A

Cryptomerin A

C31H20O10 (552.1056)


   

4-O-Methylcupressuflavone

4-O-Methylcupressuflavone

C31H20O10 (552.1056)


   

7-O-Methylochnaflavone

7-O-Methylochnaflavone

C31H20O10 (552.1056)


   

8)-4,5,7-trihydroxyflavone

5-Hydroxy-7-methoxyflavone-(4 -

C31H20O10 (552.1056)


   

4-O-Methylagathisflavone

4-O-Methylagathisflavone

C31H20O10 (552.1056)


   

CHEMBL3589107

CHEMBL3589107

C31H20O10 (552.1056)


   

7-Methoxy-4,4,5,5,7-pentahydroxy-3,6-biflavone

7-Methoxy-4,4,5,5,7-pentahydroxy-3,6-biflavone

C31H20O10 (552.1056)


   

4-O-Methylochnaflavone

4-O-Methylochnaflavone

C31H20O10 (552.1056)


   

amentoflavone|podocarpusflavone A

amentoflavone|podocarpusflavone A

C31H20O10 (552.1056)


   

Cryptomerin A|Hinokiflavon-monomethylaether

Cryptomerin A|Hinokiflavon-monomethylaether

C31H20O10 (552.1056)


   

Isocryptomerin

Isocryptomerin

C31H20O10 (552.1056)


   

3-O-methyl loniflavone

3-O-methyl loniflavone

C31H20O10 (552.1056)


   

Cupressuflavone-7-methyl ether

Cupressuflavone-7-methyl ether

C31H20O10 (552.1056)


   
   

CHEMBL4449738

CHEMBL4449738

C31H20O10 (552.1056)


   

7-O-Methyltaiwaniaflavone

7-O-Methyltaiwaniaflavone

C31H20O10 (552.1056)


   

4-O-methylagathisflavone|ouratine B

4-O-methylagathisflavone|ouratine B

C31H20O10 (552.1056)


   

8-(4-Methoxy-5,7-dihydroxyflavone-8-yl)-4,5,7-trihydroxyflavone

8-(4-Methoxy-5,7-dihydroxyflavone-8-yl)-4,5,7-trihydroxyflavone

C31H20O10 (552.1056)


   

Ochnaflavone-7'-O-methyl ether

Ochnaflavone-7"-O-methyl ether

C31H20O10 (552.1056)


   

5-Hydroxy-7-methoxyflavone-(4 ->O -> 8)-4,5,7-trihydroxyflavone

5-Hydroxy-7-methoxyflavone-(4 ->O -> 8)-4,5,7-trihydroxyflavone

C31H20O10 (552.1056)


   

Isocyptomerin

6-(4-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)phenoxy)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

C31H20O10 (552.1056)


Isocryptomerin is a natural product found in Chamaecyparis obtusa, Cupressus sempervirens, and other organisms with data available.

   

3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

NCGC00380577-01!3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

C31H20O10 (552.1056)


   

O-Methylamentoflavone

O-Methylamentoflavone

C31H20O10 (552.1056)


   

Biflavonoid-flavone base + 3O and flavone base + 2O + 1MeO

Biflavonoid-flavone base + 3O and flavone base + 2O + 1MeO

C31H20O10 (552.1056)


Annotation level-3

   

Bilobetin

8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one

C31H20O10 (552.1056)


Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1]. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity[1].

   

10-[1,1-Biphenyl]-4-yl-2-(1-methylethyl)-9-oxo-9H-thioxanthenium hexafluorophosphate

10-[1,1-Biphenyl]-4-yl-2-(1-methylethyl)-9-oxo-9H-thioxanthenium hexafluorophosphate

C28H23F6OPS (552.1111)


   

2-[[(2S,4S,5R)-4-[(2R,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-5-(hydroxymethyl)pyrrolidin-1-ium-2-carbonyl]amino]ethanesulfonic acid

2-[[(2S,4S,5R)-4-[(2R,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-5-(hydroxymethyl)pyrrolidin-1-ium-2-carbonyl]amino]ethanesulfonic acid

C16H30N3O14S2+ (552.1169)


   

41583-83-9

4H-1-Benzopyran-4-one, 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, monomethyl ether

C31H20O10 (552.1056)


   
   

3-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

3-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

C31H20O10 (552.1056)


   

6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one

6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one

C31H20O10 (552.1056)


   

5,7-dihydroxy-8-[4-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenoxy]-2-(4-hydroxyphenyl)chromen-4-one

5,7-dihydroxy-8-[4-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenoxy]-2-(4-hydroxyphenyl)chromen-4-one

C31H20O10 (552.1056)


   

2,3-bis(formyloxy)propoxy([(1s,2r,3s,4s,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]oxy)phosphinic acid

2,3-bis(formyloxy)propoxy([(1s,2r,3s,4s,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]oxy)phosphinic acid

C17H29O18P (552.1091)


   

5,5',7-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7'-methoxy-[8,8'-bichromene]-4,4'-dione

5,5',7-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7'-methoxy-[8,8'-bichromene]-4,4'-dione

C31H20O10 (552.1056)


   

2-{4-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-3-methoxyphenyl}-5,7-dihydroxychromen-4-one

2-{4-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-3-methoxyphenyl}-5,7-dihydroxychromen-4-one

C31H20O10 (552.1056)


   

5,7-dihydroxy-6-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-2-(4-hydroxyphenyl)chromen-4-one

5,7-dihydroxy-6-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-2-(4-hydroxyphenyl)chromen-4-one

C31H20O10 (552.1056)


   

5,5',7'-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7-methoxy-[6,8'-bichromene]-4,4'-dione

5,5',7'-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7-methoxy-[6,8'-bichromene]-4,4'-dione

C31H20O10 (552.1056)


   

6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

C31H20O10 (552.1056)


   

5,7-dihydroxy-3-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-2-(4-hydroxyphenyl)chromen-4-one

5,7-dihydroxy-3-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-2-(4-hydroxyphenyl)chromen-4-one

C31H20O10 (552.1056)


   

5,5',7,7'-tetrahydroxy-2-(4-hydroxyphenyl)-2'-(4-methoxyphenyl)-[6,8'-bichromene]-4,4'-dione

5,5',7,7'-tetrahydroxy-2-(4-hydroxyphenyl)-2'-(4-methoxyphenyl)-[6,8'-bichromene]-4,4'-dione

C31H20O10 (552.1056)


   

8-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

8-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one

C31H20O10 (552.1056)


   

5,5',7,7'-tetrahydroxy-2'-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-[3,6'-bichromene]-4,4'-dione

5,5',7,7'-tetrahydroxy-2'-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-[3,6'-bichromene]-4,4'-dione

C31H20O10 (552.1056)


   

5,5',7-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7'-methoxy-[6,8'-bichromene]-4,4'-dione

5,5',7-trihydroxy-2,2'-bis(4-hydroxyphenyl)-7'-methoxy-[6,8'-bichromene]-4,4'-dione

C31H20O10 (552.1056)


   

6-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one

6-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one

C31H20O10 (552.1056)